Journals / Viral Hepatitis Journal / 2014 / Cilt: 20 - Sayı: 3

Batman’da Gebelerde ve HBsAg Pozitif Anneden Doğan Yenidoğanlarda HBsAg Seroprevalansı

Seroprevalance of Hepatitis B among Pregnant Women and Neonates Born to HBsAg Positive Mothers in Batman

Pages
115–119
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The identification and close follow-up of HBsAg-positive mothers is essential to make the complete and appropriate immunoprophylaxis in all neonates born to HBsAg- positive mothers and to prevent transmission of HBV.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The aim of this study was to determine hepatitis B surface antijen (HBsAg) seroprevalence among pregnant women and neonates born to HBsAg- positive mothers admitted to Batman Gynecology, Obstetrics and Pediatrics Hospital located in Batman Province in, the Southeastern Anatolian Region of Turkey.
📊
Key Findings & Data:Materials and Methods: All pregnant women admitted to the obstetrics and gynecology unit between April 2008 and December 2010 were screened for HBsAg.
💡
Conclusion & Impact:The identification and close follow-up of HBsAg-positive mothers is essential to make the complete and appropriate immunoprophylaxis in all neonates born to HBsAg- positive mothers and to prevent transmission of HBV.
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: The aim of this study was to determine hepatitis B surface antijen (HBsAg) seroprevalence among pregnant women and neonates born to HBsAg- positive mothers admitted to Batman Gynecology, Obstetrics and Pediatrics Hospital located in Batman Province in, the Southeastern Anatolian Region of Turkey. Materials and Methods: All pregnant women admitted to the obstetrics and gynecology unit between April 2008 and December 2010 were screened for HBsAg. Neonates born to HBsAg-positive mothers were also evaluated once for HBsAg seropositivity between 6 and 9 months of age. HBsAg presence was measured by the electrochemiluminescence immunoassay method using Modular analytics E170 analyser according to the manufacturer’s recommendations. Results: The mean age of the pregnant women was 30.13±6.58 years. 15585 consecutive pregnant women were screened for HBsAg, retrospectively. HBsAg positivity rate was found to be 4.2% (668/15585) in the pregnant women while it was 20.5% (137/668) in neonates born to HBsAg-positive mothers between 6 to 9 months of age. Conclusion: These findings demonstrate the prevalence of HBsAg among pregnant women and neonates born to HBsAg-positive mothers in Batman. Although HBsAg seropositivity rate among the pregnant women was found to be similar to the rates that were reported in other studies from the Southeastern Anatolian Region of Turkey. The fact that this rate was high for the neonates born to HBsAg-positive mothers was attributed to the insufficient immunoprophylaxis of the neonates. The identification and close follow-up of HBsAg-positive mothers is essential to make the complete and appropriate immunoprophylaxis in all neonates born to HBsAg- positive mothers and to prevent transmission of HBV.

Özet

Amaç: Bu çalışmanın amacı, Batman Kadın Doğum ve Çocuk Hastalıkları Hastanesi’ne başvuran gebe kadınlarda ve hepatit B yüzey antijenini (HBsAg) pozitif annelerden doğan yenidoğanlarda HBsAg seroprevalansının araştırılmasıdır. Gereç ve Yöntemler: Nisan 2008-Aralık 2010 tarihleri arasında Kadın Doğum kliniğine başvuran gebe kadınlar HBsAg varlığı açısından taranmıştır. Ayrıca, HBsAg pozitif annelerden doğan bebekler 6-9 aylık dönemlerinde bir kez HBsAg pozitifliği açısından değerlendirilmiştir. HBsAg varlığı elektrokemilüminesans enzim immunoassay yöntemi ile Modular Analytics E170 analizöründe üretici firma önerileri doğrultusunda araştırılmıştır. Bulgular: Çalışmaya alınan gebe hastaların yaş ortalaması 30,13±6,58 yıl idi. Çalışmaya HBsAg açısından ardışık olarak taranan 15585 gebe dahil edilmiş ve HBsAg sonuçları retrospektif olarak değerlendirilmiştir. Gebelerde HBsAg pozitiflik oranı %4,2 (668/15585) olarak saptanırken, HBsAg pozitif annelerden doğan yenidoğanların 6.-9. aylık dönemlerinde ölçüldüğünde bu oran %20,5 (137/668) olarak bulunmuştur. Sonuç: Bu bulgular Batman’da gebe kadınlarda ve HBsAg pozitif annelerden doğan yenidoğanlarda seroprevalansını göstermektedir. HBsAg seropozitiflik oranı Türkiye’nin Güneydoğu Anadolu bölgesinde daha önce bildirilmiş çalışmalarla benzer oranda bulunmuş olmasına rağmen, HBsAg pozitif annelerden doğan yenidoğanlarda bu oran yüksek bulunmuştur ve bu durum yenidoğanlara immunoprofilaksinin yetersiz uygulanması ile açıklanabilir. HBsAg pozitif anneden doğan yenidoğanlara tam ve uygun immunoprofilaksinin yapılması ve HBV bulaşının önlenmesi için gereklidir.

🔖

Cite This Article

ÇEVİK, E., İNAN, N., ŞENTÜRK, M. B., DEMİREL, A., KUMBASAR, H., ARISOY, A., SÖNMEZ, E. (2014). Batman’da Gebelerde ve HBsAg Pozitif Anneden Doğan Yenidoğanlarda HBsAg Seroprevalansı. Viral Hepatitis Journal, Cilt: 20 - Sayı: 3, 115–119. https://ajindex.com/articles/332833

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Papaevangelou v, hadjichristodoulou C, Cassiomos D, Theodoridou M. adherence to the screening program for hBv infection in pregnant women delivering in Greece. BMC Infect Dis. 2006; 6: 84. 2. altinbas S, erdogan M, Danisman n. The Seroprevalence of hBsag and anti-hCv in pregnant women in ankara. arch Gynecol obstet. 2010; 281(2): 371
  2. Coskun eİ, Dincgez B, koyucu RG, ayanoglu YT, Yumru ae. Gebelerde hBsag, antihBs ve anti-hCv sıklığı. Perinatal. 2011; 19(2): 51-102. 4. lee C, Gong Y, Brok J, Boxall eh, Gluud C. effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta- analysis. BMJ. 2006; 332(7537): 328-336
  3. Reddick kl, Jhaveri R, Gandhi M, James ah, Swamy Gk. Pregnancy outcomes associated with viral hepatitis. J viral hepat. 2011; 18(7):394-398
  4. Safir a, levy a, Sikuler e, Sheiner e. Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome. liver Int. 2010; 30(5): 765-770. 7. lee nM, Brady CW. liver Disease in pregnancy. World J Gastroenterol. 2009; 15(8): 897-906. 8. kolgelier S, Demir lS, Demir na, özçimen S, Tabak S. adıyaman İlindeki Gebelerde hBsag ve anti-hCv Pozitifliği. vir hep Derg. 2012; 18(3): 98-101
  5. Gambarin-Gelwan M. hepatitis B in pregnancy. Clin liver Dis. 2007; 11: 945-963
  6. Yogeswaran k, Fung Sk. Chronic hepatitis B in pregnancy:unique challenges and opportunities. korean J hepatol. 2011; 17: 1-8
  7. Tran TT. Management of hepatitis B in pregnancy: Weighing the options. Cleve Clin J Med. 2009; 76(Suppl 3): 25-29
  8. Wiseman e, Fraser Ma, holden S, Glass a, kidson Bl, heron lG, Maley MW, ayres a, locarnini Sa, levy MT. Perinatal transmission of hepatitis B virus: an australian experience. Med J aust. 2009; 190(9): 489-492
  9. Dwivedi M, Misra SP, Misra v, Pandey a, Pant S, Singh R, verma M. Serorevalence of hepatitis B infection during pregnancy and risk of perinatal transmission. Indian J Gastroenterol. 2011; 30(2): 66-71
  10. Mıstık R, Balık İ. Türkiye’de viral hepatitlerin epidemiyolojik analizi.ed. kılıçturgay k, Badur S. viral hepatit. 2001. İstanbul.2001:10-55
  11. Tekay F, özbek e. Şanlıurfa kadın hastalıkları ve Doğum hastanesine Başvuran kadınlarda hepatit B, hepatit C ve insan immun yetmezlik virüsü seropozitifliği. Mikrobiyol Bült. 2006; 40: 369-373. 16. erdem M, Şahin I, erdem a, Gürsoy R, Yildiz a, Güner h. Prevalence of hepatitis B surface antijen among pregnant w